Health commissioner says plan is to reduce hospitalisation and tackle long-term impact of Covid
Three Covid medicines with the potential to “change the course” of the pandemic will be authorised for mass production and use in the EU by October under a European Commission plan.
Stella Kyriakides, the commissioner for health, said such a move would reduce hospitalisation and tackle the long-term impact of Covid, with one in 10 people reporting symptoms 12 weeks after infection.
Related: EU ‘ready to discuss’ waiver on Covid vaccine patents
